2744 Organometallics, Vol. 24, No. 11, 2005
Brunker et al.
2
7, 8, CH), 18.2-18.0 (m, Me), 16.2-16.1 (m, Me), 15.1-15.0
(d, J ) 1, CH
20, CH), 31.7 (d, J ) 29, CH), 25.7 (apparent t, J ) 22, CH
21.2 (dd, J ) 16, 12, CH ), 20.0 (d, J ) 11, Me), 19.0 (d, J ) 8,
Me), 14.6 (d, J ) 1, Me), 13.8 (d, J ) 1, Me).
Pd((S,S)-Me-FerroLANE)(Ph)(I) (3e). Anal. Calcd for
37FeIP Pd: C, 46.41; H, 5.15. Found: C, 46.22; H, 5.07.
2
), 35.6 (d, J ) 3, CH
2
), 35.0 (CH
2
), 33.5 (d, J )
(
1
5
m, Me), 14.8-14.7 (m, Me). IR: 3044, 2922, 2855, 1650, 1622,
556, 1450, 1378, 1244, 1156, 1111, 1056, 1017, 756, 728, 694,
28, 456.
2
),
2
Pd((R,R)-Et-Duphos)(Ph)(I) (3b). Anal. Calcd for C28
41
H -
IP
2
Pd‚C
6
H
6
: C, 54.38; H, 6.31. Found: C, 54.12; H, 6.52. 31P-
C
28
H
2
1
1
31
1
1
{
H} NMR (C
): δ 7.91 (br, 2H, Ar), 7.27-7.25 (m, 3H, Ar), 7.12-7.11
m, 1H, Ar), 7.06-7.01 (m, 3H, Ar), 3.85-3.78 (m, 1H, CH),
6 6
D
): δ 61.4 (d, J ) 26), 58.5 (d, J ) 26). H NMR
P{ H} NMR (CDCl
3
): δ 41.0 (d, J ) 32), 23.9 (d, J ) 32). H
(
(
C
6
D
6
NMR (CDCl ): δ 7.41 (apparent t, J ) 8, 1H, Ar), 7.31
3
(apparent t, J ) 8, 1H, Ar), 7.10 (apparent t, J ) 8, 1H, Ar),
7.04 (apparent t, J ) 8, 1H, Ar), 6.81 (apparent t, J ) 7, 1H,
Ar), 4.57 (m, 1H, Cp), 4.53 (m, 1H, Cp), 4.44 (m, 1H, Cp), 4.40
(m, 3H, Cp), 4.21 (m, 1H, Cp), 4.13 (m, 1H, Cp), 3.95-3.87
(m, 1H), 2.79-2.72 (m, 1H), 2.63-2.56 (m, 1H), 2.24-2.10 (m,
2H), 2.00-1.94 (m, 1H), 1.96 (dd, J ) 7, 1, 3H, Me), 1.92 (d, J
) 7, 3H, Me), 1.82-1.74 (m, 1H), 1.65-1.55 (m, 1H), 1.36-
1.11 (m, 3H), 1.10-1.02 (m, 1H), 0.90 (dd, J ) 15, 7, 3H, Me),
3
.02-2.94 (m, 1H, CH), 2.46-2.39 (m, 1H, CH), 2.30-2.18 (m,
H, CH ), 2.13-1.93 (m, 5H, 2 CH , CH), 1.87-1.53 (m, 4H, 2
), 1.37-1.10 (m, 4H, 2 CH ), 1.03-0.93 (m, 2H, CH ), 0.92
overlapping dd, JHH ) 7, 7, 3H, Me), 0.79 (overlapping dd,
2
CH
2
2
2
2
2
3
(
3
3
J
HH ) 7, 7, 3H, Me), 0.74 (overlapping dd, JHH ) 7, 7, 3H,
3
13
1
Me), 0.69 (overlapping dd, JHH ) 7, 7, 3H, Me). C{ H} NMR
): δ 158.2 (d, J ) 138, Ar, quat), 144.8 (dd, J ) 52, 33,
Ar, quat), 144.6 (dd, J ) 34, 24, Ar, quat), 140.1 (br, Ar, CH),
6 6
(C D
1
3
1
3
0.51 (dd, J ) 16, 7, 3H, Me). C{ H} NMR (CDCl ): δ 153.5
1
34.0 (d, J ) 15, Ar, CH), 133.2 (d, J ) 16, Ar, CH), 131.1-
31.0 (m, Ar, CH), 130.9 (d, J ) 5, Ar, CH), 127.6 (d, J ) 9,
(dd, J ) 122, 3, Ar quat), 138.1 (apparent t, J ) 3, Ar), 135.8
(d, J ) 5, Ar), 128.4 (d, J ) 9, Ar), 127.8 (d, J ) 8, Ar), 122.7
(Ar), 75.0 (Cp CH), 74.9 (Cp CH), 74.3 (Cp CH), 74.1 (d, J ) 2,
Cp CH), 73.6 (dd, J ) 33, 7, Cp quat), 72.5 (Cp CH), 72.3 (d,
J ) 2, Cp CH), 71.9 (d, J ) 2, Cp CH), 71.6 (d, J ) 2, Cp CH),
70.7 (dd, J ) 21, 3, Cp quat), 38.3 (d, J ) 21, CH), 36.7 (d, J
1
Ar, CH), 123.6 (Ar, CH), 51.3 (d, J ) 27, CH), 50.8 (d, J ) 19,
CH), 44.4 (d, J ) 20, CH), 40.5 (d, J ) 26, CH), 35.2 (d, J ) 2,
CH
6.7 (d, J ) 11, CH
CH ), 24.2 (d, J ) 2, CH
2
), 34.4 (d, J ) 3, CH
), 24.9 (d, J ) 8, CH
), 15.2 (d, J ) 11, Me), 15.0 (d, J )
2
), 34.3 (CH
2
), 32.9 (d, J ) 6, CH
2
),
2
2
2
), 24.3 (d, J ) 1,
2
2
) 28, CH), 36.4 (overlapping, 2 × CH
35.3 (d, J ) 32, CH), 34.7 (d, J ) 22, CH), 34.2 (CH
J ) 13, Me), 21.1 (d, J ) 11, Me), 14.7 (Me), 14.2 (Me).
2
), 36.2 (d, J ) 3, CH
2
),
1
2, Me), 14.3 (d, J ) 8, Me), 14.2 (d, J ) 9, Me).
2
), 21.6 (d,
49
Pd((R,R)-i-Pr-Duphos)(Ph)(I) (3c). Anal. Calcd for C32H -
3
1
1
IP
2
Pd: C, 52.72; H, 6.78. Found: C, 52.81; H, 6.98. P{ H}
Pd((S,S)-Me-DuXantphos)(Ph)(I) (3f). Anal. Calcd for
1
NMR (CDCl
CDCl ): δ 7.81-7.75 (m, 1H, Ar), 7.69-7.68 (m, 1H, Ar),
.61-7.51 (m, 4H, Ar), 7.09-7.07 (m, 2H, Ar), 6.90-6.87 (m,
H, Ar), 3.46-3.41 (m, 1H, CH), 2.83-2.77 (m, 1H, CH), 2.69-
.60 (m, 1H, CH), 2.44-2.19 (m, 5H, 2 CH , CH), 2.06-1.89
, 2CH), 1.69-1.49 (m, 3H, CH , CH), 1.34-1.23
3
): δ 62.4 (d, J ) 23), 57.0 (d, J ) 23). H NMR
C
33
H
41
P
2
OIPd(CH
2
Cl
2
)
0.5: C, 50.84; H, 5.35. Found: C, 50.64;
1
(
3
H, 5.53. The presence of CH
2
Cl
spectroscopy. P{ H} NMR (CD
(d, J ) 32), 27.1 (d, J ) 32) (B); ratio A:B 3.2:1. P{ H} NMR
2
was confirmed by H NMR
3
1
1
7
1
2
2 2
Cl , -50 °C): δ 31.7 (A); 36.2
3
1
1
1
2
2 2 2 2
(CD Cl , 21 °C): δ 31.3 (br). H NMR (CD Cl , -50 °C): δ 7.71
(
(
m, 4H, CH
2
2
(m, 2H, Ar, A), 7.62 (d, J ) 8, 1H, Ar, B), 7.54 (dd, J ) 7, 1,
1H, Ar, B), 7.54-7.32 (overlapping m, 5H, Ar, A), 7.24-7.21
(overlapping m, 2H, Ar, B), 7.20 (d, J ) 7, 2H, Ar, B), 7.15 (t
of d, J ) 7, 1, 1H, Ar, B), 7.07 (t, J ) 7, 2H, Ar, A), 6.96 (t, J
) 7, 1H, Ar, A), 6.92 (t, J ) 8, 1H, Ar, A), 6.79 (m, 1H, Ar, B),
6.69 (t, J ) 7, 1H, Ar, B), 6.61 (br t, J ) 7, 1H, Ar, B), 5.86 (br
m, 1H, Ar, B), 3.48 (m, 1H, B), 2.92 (m, 1H, B), 2.81-2.77 (m,
2H, A), 2.65-2.60 (m, 4H, A), 2.57-2.45 (m, 2H, B), 2.38-
2.27 (m, 1H, B), 2.26-2.13 (m, 2H, A), 2.12-2.06 (m, 2H, A),
2.04-2.01 (m, 1H, B), 1.92 (3H, Xant Me B), 1.83-1.76 (m,
2H, B), 1.70 (6H, Xant Me, A), 1.66-1.62 (overlapping m, 1H,
B), 1.62 (dd, J ) 12, 5, 3H, Me, B), 1.58 (dd, J ) 20, 7, 3H,
Me, B), 1.45 (dd, J ) 19, 7, 3H, Me, B), 1.36 (3H, Xant Me B),
1.29-1.24 (m, 2H, B), 1.23-1.20 (overlapping m, 1H, B), 1.20-
1.14 (m, 6H, Me, A), 1.09-1.01 (m, 2H, A), 0.92 (dd, J ) 10, 7,
Me, 6H, A), 0.27 (dd, J ) 13, 7, 3H, Me, B).
3
3
m, 1H, CH), 1.12 (d, JHH ) 6, 3H, Me), 1.06 (d, JHH ) 6, 3H,
Me), 0.93 (d, JHH ) 6, 3H, Me), 0.89 (d, JHH ) 6, 3H, Me),
3
3
3
0
.86 (d, JHH ) 6, 3H, Me), 0.74-0.71 (two overlapping d, JHH
3
13
1
)
7, 6H, Me), 0.66 (d,
JHH ) 6, 3H, Me). C{ H} NMR
(
CDCl
3
): δ 156.4 (d, J ) 134, Ar, quat), 144.9 (dd, J ) 31, 16,
quat), 144.6 (dd, J ) 32, 5, quat), 134.7 (d, J ) 15, Ar, CH),
33.6 (d, J ) 17, Ar, CH), 131.8 (m, Ar, CH), 131.4 (m, Ar,
1
CH), 127.7 (d, J ) 8, Ar, CH), 123.4 (Ar, CH), 56.7-56.6 (m,
CH), 51.6 (d, J ) 18, CH), 47.2 (d, J ) 33, CH), 32.9 (d, J ) 2,
CH
3
2
)
8
2
), 32.35 (d, J ) 3, CH
0.9 (d, J ) 6, CH ), 30.1 (d, J ) 7, CH), 29.6 (d, J ) 2, CH),
8.6 (CH), 26.9 (d, J ) 8, Me), 26.7 (d, J ) 4, Me), 26.0 (d, J
2 2
), 32.04 (CH ), 32.02 (d, J ) 10, CH),
2
6, Me), 25.1 (d, J ) 6, Me), 22.7 (d, J ) 7, Me), 22.6 (d, J )
, Me), 21.6 (d, J ) 6, Me), 21.5 (d, J ) 7, Me).
Pd((R,R)-Me-BPE)(Ph)(I) (3d). Pd(TMEDA)(Ph)(I) (53
mg, 0.12 mmol) was slurried in THF (1 mL), and a solution of
Complex 3f was also generated in toluene by oxidative
addition of PhI to impure Pd(Me-DuXantphos)(trans-stilbene)
(
R,R)-Me-BPE (32 mg, 0.12 mmol) in THF (1 mL) was added
slowly. All the solid dissolved initially; then a white precipitate
formed. The reaction mixture was stirred for 45 min, and then
all volatiles were removed in vacuo to give a pale orange solid,
which was washed with petroleum ether (3 mL). The residue
or to Pd(dba)
2
/Me-DuXantphos. In the latter experiment, at
room temperature, four broadened peaks were observed in the
31
1
P{ H} NMR spectrum, which sharpened upon cooling to -20
°C. The AB pattern (toluene, -20 °C; δ 30.8, 25.3 (J ) 417))
was consistent with trans-Pd(Me-DuXantphos)(Ph)(I). Removal
was dried and then redissolved in CH
Layering this solution with Et O (12 mL) and storage at -30
C for 1 week yielded a fine white fluffy solid (pure by NMR
2 2
Cl (3 mL) and filtered.
2
of the solvent in vacuo and dissolution of the residue in CD
Cl gave spectra similar to those of an authentic sample
(prepared by the method above) in the same solvent.
2
-
°
2
spectroscopy) as well as some larger yellow crystalline pieces
which were suitable for elemental analysis. Yield: 50 mg
Pd((S,S)-Et-FerroTANE)(Ph)(I) (3g). Anal. Calcd for
(
0.088 mmol, 70%).
Anal. Calcd for C20
C H FeIP Pd: C, 47.87; H, 5.49. Found: C, 48.03; H, 5.58.
3
0
41
2
3
1
1
1
H
33
P
2
PdI: C, 42.24; H, 5.85. Found: C,
): δ 72.9 (d, J ) 25), 61.5
): δ 7.41 (t, J ) 7, 2H, Ph), 7.05
P{ H} NMR (CDCl
3
): δ 46.4 (d, J ) 29), 32.8 (d, J ) 29). H
3
1
1
4
2.16; H, 6.14. P{ H} NMR (CDCl
3
NMR (CDCl ): δ 7.65 (br t, J ) 6, 1H, Ph), 7.13 (br, 2H, Ph)
3
1
(
(
(
d, J ) 25). H NMR (CDCl
3
7.03 (br, 1H, Ph), 6.85 (t of d, J ) 7, 1, 1H, Ph), 4.65 (m, 1H,
Cp), 4.62 (m, 1H, Cp), 4.50 (m, 1H, Cp), 4.48 (m, 3H, Cp), 4.35
(m, 1H, Cp), 4.26 (m, 1H, Cp), 4.14 (quintet, J ) 9, 1H), 2.60-
2.52 (m, 2H), 2.47-2.33 (m, 3H), 2.30-2.17 (m, 2H), 2.13-
1.89 (m, 3H), 1.56-1.51 (m, 1H), 1.41 (t, J ) 7, 3H, Me), 1.35
(t, J ) 7, 3H, Me), 1.15-1.10 (m, 2H), 1.07-1.00 (m, 1H), 0.90-
0.82 (m, 1H), 0.79 (t, J ) 7, 3H, Me), 0.44 (t, J ) 7, 3H, Me).
t of d, J ) 8, 3, 2H, Ph), 6.84 (t of d, J ) 8, 1, 1H, Ph), 3.44
m, 1H), 2.32-2.20 (m, 2H), 2.14-1.71 (overlapping m, 8H),
1
.65-1.56 (m, 1H), 1.51 (dd, J ) 18, 7, 3H, Me), 1.46 (partially
obscured m, 2H), 1.41 (dd, J ) 19, 7, 3H, Me), 1.38-1.25 (m,
1
1
H), 1.22 (dd, J ) 14, 7, 3H, Me), 1.18 (dd, J ) 15, 7, 3H, Me),
13
1
3
.05-0.95 (m, 1H). C{ H} NMR (CDCl ): δ 158.9 (d, J ) 132,
1
3
1
Ph quat), 137.6 (Ph), 127.2 (d, J ) 9, Ph), 122.5 (Ph), 39.2 (d,
J ) 26, CH), 39.1 (d, J ) 19, CH), 36.8 (d, J ) 3, CH ), 36.0
C{ H} NMR (THF-d
8
): δ 155.9 (dd, J ) 127, 5, quat Pd-
2
6 5
C H ), 141.1 (br), 137.4 (br m), 128.1 (d, J ) 9), 123.0, 79.1 (d,